Benign childhood epilepsy with centro-temporal spikes, BECT
Conditions
Interventions
A1:levetiracetam
A2:oxcarbazepine
B1:levetiracetam
B2:oxcarbazepine
Sponsors
West China Second Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
3 Years to 15 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed according to the criteria of seizure and epilepsy syndrome set by ILAE in 2010; 2. The patients aged from 3 to 15 years old were selected; 3. Patients with epilepsy attack completely at night or early in the morning; 4. Patients with focal attack, generalized attack or focal secondary generalized attack; 5. Patients with attack frequency more than 2 times / year; 6. Electroencephalogram was consistent with: normal background activity, spikes or sharp waves repeatedly appeared in the central and / or temporal region; 7. Patients who did not receive any antiepileptic drugs; 8. Patients with normal blood routine, liver and kidney function and electrolytes in the two groups before treatment; 9. This study was reported to the hospital ethics committee for approval, and all children's families were informed of the research items and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with head space occupying lesions, vascular malformations and other nervous system diseases; 2. Patients with severe heart, liver and kidney dysfunction; 3. Patients with poor treatment compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seizure free control rate;Cognitive function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events; | — |
Countries
China
Contacts
Public ContactJing Gan
Department of Pediatric Neurology, West China Second Hospital of Sichuan University
Outcome results
None listed